Jasper Therapeutics Stock Technical Analysis
| JSPR Stock | USD 23.24 0.61 2.70% |
As of the 29th of November, Jasper Therapeutics retains the Risk Adjusted Performance of 0.0597, downside deviation of 5.09, and Market Risk Adjusted Performance of 0.12. Jasper Therapeutics technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Jasper Therapeutics variance and potential upside to decide if Jasper Therapeutics is priced fairly, providing market reflects its last-minute price of 23.24 per share. Given that Jasper Therapeutics has jensen alpha of (0.02), we strongly advise you to confirm Jasper Therapeutics's regular market performance to make sure the company can sustain itself at a future point.
Jasper Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Jasper, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to JasperJasper |
Jasper Therapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 7.0 | Strong Buy | 10 | Odds |
Most Jasper analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Jasper stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Jasper Therapeutics, talking to its executives and customers, or listening to Jasper conference calls.
Jasper Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Jasper Therapeutics Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Jasper Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Jasper Therapeutics Trend Analysis
Use this graph to draw trend lines for Jasper Therapeutics. You can use it to identify possible trend reversals for Jasper Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Jasper Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Jasper Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Jasper Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.05 , which means Jasper Therapeutics will continue generating value for investors. It has 122 observation points and a regression sum of squares at 94.98, which is the sum of squared deviations for the predicted Jasper Therapeutics price change compared to its average price change.About Jasper Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Jasper Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Jasper Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Jasper Therapeutics price pattern first instead of the macroeconomic environment surrounding Jasper Therapeutics. By analyzing Jasper Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Jasper Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Jasper Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 | 2024 (projected) | Current Ratio | 10.95 | 5.91 | 7.19 | 9.43 | Net Debt To EBITDA | 2.63 | 0.91 | 1.29 | 1.23 |
Jasper Therapeutics November 29, 2024 Technical Indicators
Most technical analysis of Jasper help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Jasper from various momentum indicators to cycle indicators. When you analyze Jasper charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0597 | |||
| Market Risk Adjusted Performance | 0.12 | |||
| Mean Deviation | 3.47 | |||
| Semi Deviation | 4.82 | |||
| Downside Deviation | 5.09 | |||
| Coefficient Of Variation | 1495.85 | |||
| Standard Deviation | 4.97 | |||
| Variance | 24.69 | |||
| Information Ratio | 0.0416 | |||
| Jensen Alpha | (0.02) | |||
| Total Risk Alpha | (0.43) | |||
| Sortino Ratio | 0.0407 | |||
| Treynor Ratio | 0.11 | |||
| Maximum Drawdown | 24.85 | |||
| Value At Risk | (8.03) | |||
| Potential Upside | 9.08 | |||
| Downside Variance | 25.88 | |||
| Semi Variance | 23.19 | |||
| Expected Short fall | (3.69) | |||
| Skewness | (0.38) | |||
| Kurtosis | 1.94 |
Additional Tools for Jasper Stock Analysis
When running Jasper Therapeutics' price analysis, check to measure Jasper Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jasper Therapeutics is operating at the current time. Most of Jasper Therapeutics' value examination focuses on studying past and present price action to predict the probability of Jasper Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jasper Therapeutics' price. Additionally, you may evaluate how the addition of Jasper Therapeutics to your portfolios can decrease your overall portfolio volatility.